This is a good distribution arrangement but am I right in assuming there is no recurring revenue from monitoring for GMV with this agreement ?
Perhaps GMV plans to focus on RR for the patch which will hopefully be FDA approved soon and this announcement is GMV focussing on getting the first product out there ASAP?
Thoughts?
- Forums
- ASX - By Stock
- Ann: USA distribution agreement secured with LiveCare for Prizma
This is a good distribution arrangement but am I right in...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)